2025-12-10 – Press Releases – www.prnewswire.com
SHANGHAI, Dec. 10, 2025 /PRNewswire/ — D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completion of a $108 million Series B financing round. The funding round was backed by a distinguished…
